The Competition Commission of Pakistan (CCP) has granted formal approval for the proposed acquisition of a major shareholding in Engro Polymer & Chemicals Limited (EPCL) by Lotte Chemical Pakistan Limited (LCPL) from Engro Corporation Limited. The regulatory clearance follows a comprehensive Phase-I competition assessment conducted under the Competition Act, 2010.
Overview of the Merging Entities
Lotte Chemical Pakistan Limited operates as a public limited company primarily engaged in the manufacturing and supply of Purified Terephthalic Acid (PTA) within Pakistan. PTA serves as an essential raw material utilized heavily in the production of polyester and polyethylene terephthalate (PET). Meanwhile, the target company, Engro Polymer & Chemicals Limited, specializes in the production and distribution of Polyvinyl Chloride (PVC), caustic soda, hydrogen peroxide, and various other chlor-alkali products. The intent to execute this acquisition was initially announced by LCPL earlier in the year.
Also Read: Musk Confirms Merger Talks Between SpaceX and Tesla As Independent Committees Convene
Regulatory Assessment and Market Dynamics
To evaluate the competitive implications of the deal, the CCP defined the relevant product markets as PVC, caustic soda, and hydrogen peroxide, with the geographic market encompassing the entirety of Pakistan.
The regulatory assessment revealed that LCPL does not operate within any of these identified relevant product markets. Furthermore, neither LCPL nor any of its associated, affiliated, or group entities procure products from EPCL. As a result, the commission established that the transaction generates neither a horizontal overlap between competing entities nor a vertical relationship between a supplier and a buyer.
In evaluating specific segments, the CCP noted that while EPCL acts as the sole domestic manufacturer of PVC, it faces significant competitive constraints from international imports. In the markets for caustic soda and hydrogen peroxide, EPCL maintains lower market shares and competes directly alongside multiple independent market participants.
Impact on Market Concentration and Final Authorization
The competition watchdog observed that the transaction fundamentally represents a structural transfer of ownership and control over EPCL. In isolation, the deal does not directly increase the target company’s production capacity, sales volume, or output. Consequently, the regulator does not expect the acquisition to elevate market concentration, erect new barriers to entry, or unduly enhance the market power of either corporate party.
Concluding its Phase-I review, the CCP determined that the acquisition is unlikely to substantially lessen competition or create or strengthen a dominant market position. The transaction has been officially authorized under Section 31(1)(d)(i) of the Competition Act, 2010, highlighting the regulator’s objective to facilitate valuable corporate investments while preserving market efficiency and consumer welfare.